JOURNEY MEDICAL CORP (DERM)
US48115J1097 - Common Stock
ChartMill assigns a Buy % Consensus number of 82% to DERM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 10.2. This target is 76.47% above the current price.
DERM was analyzed by 10 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about DERM.
In the previous month the buy percentage consensus was at a similar level.
DERM was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-09-06 | Lake Street | Initiate | Buy |
| 2024-08-22 | Rodman & Renshaw | Initiate | Buy |
| 2024-06-28 | Roth MKM | Reiterate | Buy |
| 2024-02-16 | Alliance Global Partners | Initiate | Buy |
| 2023-09-07 | B. Riley Securities | Reiterate | Buy -> Buy |
| 2023-07-12 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-05-23 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023-03-30 | B. Riley Securities | Reiterate | Buy |
| 2022-02-25 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-12-16 | Roth Capital | Initiate | Buy |
| 2021-12-07 | B. Riley Securities | Initiate | Buy |